1. Home
  2. CTMX vs IDN Comparison

CTMX vs IDN Comparison

Compare CTMX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • IDN
  • Stock Information
  • Founded
  • CTMX 2008
  • IDN 1994
  • Country
  • CTMX United States
  • IDN United States
  • Employees
  • CTMX N/A
  • IDN N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • IDN Computer Software: Prepackaged Software
  • Sector
  • CTMX Health Care
  • IDN Technology
  • Exchange
  • CTMX Nasdaq
  • IDN Nasdaq
  • Market Cap
  • CTMX 62.3M
  • IDN 50.8M
  • IPO Year
  • CTMX 2015
  • IDN 1999
  • Fundamental
  • Price
  • CTMX $0.59
  • IDN $2.32
  • Analyst Decision
  • CTMX Buy
  • IDN Buy
  • Analyst Count
  • CTMX 6
  • IDN 3
  • Target Price
  • CTMX $5.77
  • IDN $3.33
  • AVG Volume (30 Days)
  • CTMX 3.5M
  • IDN 46.9K
  • Earning Date
  • CTMX 03-06-2025
  • IDN 05-12-2025
  • Dividend Yield
  • CTMX N/A
  • IDN N/A
  • EPS Growth
  • CTMX N/A
  • IDN N/A
  • EPS
  • CTMX 0.38
  • IDN N/A
  • Revenue
  • CTMX $138,103,000.00
  • IDN $19,236,000.00
  • Revenue This Year
  • CTMX N/A
  • IDN $2.09
  • Revenue Next Year
  • CTMX N/A
  • IDN $8.67
  • P/E Ratio
  • CTMX $1.55
  • IDN N/A
  • Revenue Growth
  • CTMX 36.45
  • IDN 5.22
  • 52 Week Low
  • CTMX $0.56
  • IDN $1.72
  • 52 Week High
  • CTMX $5.85
  • IDN $4.46
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 30.34
  • IDN 36.19
  • Support Level
  • CTMX $0.60
  • IDN $2.30
  • Resistance Level
  • CTMX $0.78
  • IDN $2.54
  • Average True Range (ATR)
  • CTMX 0.06
  • IDN 0.14
  • MACD
  • CTMX -0.00
  • IDN -0.02
  • Stochastic Oscillator
  • CTMX 13.69
  • IDN 16.67

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.

Share on Social Networks: